NAUT vs SLB · $103.4M cap vs P/E 12, rev $8.97B
Nautilus Biotechnology Inc (NAUT) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Nautilus Biotechnology Inc (NAUT) is a biotechnology company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
NAUT does not have a complete income-statement cache yet.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
NAUT currently screens at market cap $103.4M. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the NAUT and SLB stock pages for the full models.
Not investment advice.